Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11302-015-9457-4 http://scihub22266oqcxt.onion/10.1007/s11302-015-9457-4 C4529856!4529856!26059452     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Purinergic+Signal 2015 ; 11 (3): 317-9 Nephropedia Template TP {{tp|p=26059452|t=2015. Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161 |pdf=|usr=}}{{26059452}} gab.com Text Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161 JO: Purinergic Signal http://www.kidney.de/pget.php?&tw=1&pmid=26059452 #FOAvip CD39/ENTPD1 is a prototypic member of the ectonucleoside triphosphate diphosphohydrolase (ENTPDase) family on cell surface. CD39 has been reported to be a marker of regulatory immune cells and catalyzes extracellular hydrolysis of nucleotides to generate AMP and, in tandem with CD73, adenosine. We have recently found in addition that co-expression of CD39 and CD161 by human CD4+ T cells may become a biomarker of human Th17 cells. CD39 and CD161 have direct interactions that are further linked with acid sphingomyelinase (ASM). Upon activation of CD39 and CD161, the molecular interactions boost ASM bio-activity, which generates cellular ceramide to further mediate downstream signals inclusive of STAT3 and mTOR. We suggest modulation of human Th17 responsiveness by CD39 and CD161 and describe novel molecular mechanisms integrating elements of both extracellular nucleotide and sphingolipid homeostasis that are pivotal in the control of human Th17 cells and which could have therapeutic potential. Twit Text FOAVip Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161 ????Purinergic Signal http://www.kidney.de/pget.php?&tw=1&pmid=26059452 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26059452 #FOAvip English Wikipedia <ref>{{Cite pmid|26059452}}</ref> Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161 #MMPMID26059452 Bai A; Robson S Purinergic Signal 2015[Sep]; 11 (3): 317-9 PMID26059452show ga CD39/ENTPD1 is a prototypic member of the ectonucleoside triphosphate diphosphohydrolase (ENTPDase) family on cell surface. CD39 has been reported to be a marker of regulatory immune cells and catalyzes extracellular hydrolysis of nucleotides to generate AMP and, in tandem with CD73, adenosine. We have recently found in addition that co-expression of CD39 and CD161 by human CD4+ T cells may become a biomarker of human Th17 cells. CD39 and CD161 have direct interactions that are further linked with acid sphingomyelinase (ASM). Upon activation of CD39 and CD161, the molecular interactions boost ASM bio-activity, which generates cellular ceramide to further mediate downstream signals inclusive of STAT3 and mTOR. We suggest modulation of human Th17 responsiveness by CD39 and CD161 and describe novel molecular mechanisms integrating elements of both extracellular nucleotide and sphingolipid homeostasis that are pivotal in the control of human Th17 cells and which could have therapeutic potential. äBeyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161 (epmc).pdf DeepDyve Pubget Overpricing